Portfolio whitespace
Find unmet occasions, needs, formats, price points and portfolio roles with room to create value.
NPD & Portfolio Strategy
Back better innovation bets.
Innovation Intelligence brings commercial evidence into the choices that shape your pipeline, portfolio and investment—before the market makes the decision for you.
“Why aren’t our launches doing more?”
More ideas do not make a stronger portfolio. Better evidence and clearer roles do.
Where we focus
Commercial questions, answered properly.
Innovation patterns
Read the signals across launches, categories and commercial performance to understand what tends to work.
Commercial validation
Pressure-test the proposition, role, scale assumptions and route to market before the investment expands.
Pipeline choices
Prioritise concepts and sequence the portfolio around evidence, strategic fit and commercial potential.
Evidence base
Built from real commercial patterns, not theory.
5,730
Innovations analysed
The evidence base behind a CCEP Australia innovation framework developed through Irosha’s professional experience.
~$1B
NPD sales represented
Commercial performance examined across the innovation set—not an AmpliarX client outcome.
One
Decision framework
A structured way to connect market evidence, portfolio role and commercial validation.
The work
A clear path from question to decision.
01Map the portfolio
02Read the evidence
03Test the concepts
04Prioritise investment
What you leave with
Work the team can use.
- A portfolio and whitespace view
- Evidence-led innovation territories
- A commercial validation framework
- A prioritised pipeline with clear portfolio roles
Connected by design
Innovation works harder when portfolio strategy and commercial evidence meet.
Start here
Your business doesn’t need more noise.
It needs clarity, action and momentum.